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Abstract We have studied the conformation and thermal
stability of recombinant human phenylalanine hydroxylase
(hPAH) and selected truncated forms, corresponding to distinct
functional domains, by infrared spectroscopy. The secondary
structure of wild-type hPAH was estimated to be 48% K-helix,
28% extended structures, 12% L-turns and 12% non-structured
conformations. The catalytic C-terminal domain (residues 112^
452) holds most of the regular secondary structure elements,
whereas the regulatory N-terminal domain (residues 2^110)
adopts mainly an extended and disordered, flexible conforma-
tion. Thermal stability studies of the enzyme forms indicate the
existence of interactions between the two domains. Our results
also demonstrate that the conformational events involved in the
activation of hPAH by its substrate (L-Phe) are mainly related
to changes in the tertiary/quaternary structure. The activating
effect of phosphorylation, however, affects the secondary
structure of the N-terminal domain of the protein.
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1. Introduction
Mammalian phenylalanine hydroxylase (phenylalanine 4-
monooxygenase, PAH, EC 1.14.16.1) is a tetrahydrobiopter-
in-dependent enzyme that catalyzes the hydroxylation of L-
phenylalanine (L-Phe) to L-tyrosine. PAH, a 452 residue pro-
tein, is found predominantly in liver and the absence or re-
duction in catalytic activity of the human enzyme leads to a
serious disease (phenylketonuria). In this homotetrameric en-
zyme, the subunits contain an N-terminal regulatory domain,
with a phosphorylation site (Ser-16), and a C-terminal domain
with catalytic activity, which includes the tetramerization mo-
tif and whose steady-state kinetic and oligomeric properties
have recently been characterized [1]. PAH is activated by pre-
incubation with its substrate L-Phe, which seems to be an
important mechanism for regulating the degradation of this
essential amino acid in hepatocytes [2,3]. Phosphorylation/de-
phosphorylation of PAH at Ser-16 represents an additional
post-translational regulatory modi¢cation of the enzyme, as
studied in rat PAH [3] and human PAH (hPAH) [4,5]. Both
regulatory mechanisms seem to be interrelated, suggesting the
existence of interactions between the N- and C-terminal do-
mains of the protein. Thus, L-Phe enhances the rate of phos-
phorylation of hPAH by the cAMP-dependent protein kinase
(PKA) and the phosphorylated enzyme requires lower concen-
tration of L-Phe for substrate activation [5].
The 3D structure of a truncated form (containing the cata-
lytic and tetramerization domains) of the structurally and
functionally related enzyme tyrosine hydroxylase (TH) has
recently been determined [6]. Moreover, a dimeric truncated
form of hPAH containing the catalytic domain has been crys-
tallized [7] and its structure determined [8]. Although the 3D
structure of these truncated enzyme forms provides an ad-
equate frame to interpret the putative structural changes in-
duced by substrate activation, they lack the regulatory N-ter-
minal domain. In this context, spectroscopic methods, such as
infrared (IR) spectroscopy allow to directly compare the con-
formational properties of both protein domains in solution. In
the present study we have compared the secondary structure
and stability of recombinant hPAH with its C-terminal and
N-terminal domains, as well as measured the e¡ects of acti-
vation by L-Phe and phosphorylation.
2. Materials and methods
2.1. Materials
DNA primers for PCR and sequencing were synthesized on an
Applied Biosystems (ABI) model 392 synthesizer. Taq DNA polymer-
ase was from Boehringer Mannheim. DNA sequencing was carried
out by the Taq Dye DeoxyTerminator Cycle Sequencing Kit (ABI)
using an automated DNA sequencer (model 373A from ABI). Factor
Xa was obtained from New England Biolabs. Deuterium oxide was
from Sigma. The catalytic subunit of the cAMP-dependent protein
kinase (PKA) was puri¢ed from bovine heart as described [9].
2.2. Construction of vectors and site-directed mutagenesis
The wild-type (wt) cDNA of hPAH was subcloned into the pMAL-
c2 vector (New England Biolabs), and the deletion mutant forms
hPAH(Asp-112-Lys-452) (v1^111), corresponding to the catalytic do-
main, and hPAH(Ser-2-Gln-428) (v429^452), lacking the tetrameriza-
tion motif, were prepared by PCR-based site-directed mutagenesis as
described [1,10]. An N-terminal fragment, hPAH(Ser-2-Ser-110)
(v111^452) corresponding to the N-terminal domain, was constructed
by PCR mutagenesis. A premature stop signal in codon 111 was
introduced in the hPAH cDNA (pMAL vector) using the mutagenic
oligonucleotide (GTC CAT GAG CTT TCA TGA) and other primers
previously described [10]. The mutant PCR fragment was subcloned
into the XbaI/XhoI sites of the hPAH cDNA. Positive clones were
sequenced to verify the mutagenesis and to exclude other mutations.
2.3. Expression and puri¢cation of recombinant hPAH forms
Expression of wt-hPAH, hPAH(Asp-112-Lys-452) and hPAH(Ser-
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2-Gln-428) in Escherichia coli (TB1), puri¢cation of the fusion pro-
teins by a⁄nity chromatography on amylose resin followed by high-
performance size exclusion chromatography, and cleavage by factor
Xa was performed as described [1,4]. The tetrameric and dimeric
forms of wt-hPAH were separated by size exclusion chromatography
[4]. The fusion protein of the N-terminal fragment, MBP-(pep)Xa-
hPAH (Ser-2-Ser-110), containing the target sequence for factor Xa
(IEGR) was expressed in the pMAL system in E. coli and isolated.
The fusion protein was cleaved by the restriction protease at 0‡C for 6
h, at a protease to substrate ratio of 1:100 (w/w). The cleaved fusion
protein was gel ¢ltrated on a Sephadex G-25 column (1.5U7 cm),
equilibrated in 10 mM Na-HEPES, 0.2 M NaCl, pH 7.4 and then
applied to a second column of amylose resin (2.5U8 cm), equilibrated
in the same bu¡er, in order to remove MBP. The hPAH(Ser-2-Ser-
110) protein was collected in the £ow-through, and concentrated on
Centriplus 3 concentrators (Amicon, MA), and further by freeze-dry-
ing. All chromatographic steps were carried out at 4‡C.
2.4. Phosphorylation of the N-terminal domain
The cleavage of the fusion protein of wt-hPAH by factor Xa may
result in variable amounts of a truncated form of the enzyme (v13-
hPAH), which is not a substrate for PKA [4,5]. Thus, in order to
phosphorylate both wt-hPAH and its N-terminal fragment at Ser-16
with a stoichiometry of 1 mol of Pi/mol subunit or domain, phosphor-
ylation by PKA was performed on the fusion proteins prior to the
cleavage by factor Xa [5]. The fusion proteins (2 mg/ml) were incu-
bated with 8 Wg/ml catalytic subunit of bovine heart PKA, 0.03 mM
EDTA, 1 mM DTT, 63 mM MgSO4, 4 mM CaCl2, 0.5 mM [Q-
32P]ATP (or ATP) and 15 mM Na-HEPES, pH 7.5, at 30‡C. Under
these conditions, 0.9^1.0 mol phosphate was incorporated per hPAH
subunit [5] or N-terminal fragment, hPAH(Ser-2-Ser-110). After phos-
phorylation the samples were gel ¢ltered on a Sephadex G-25 column
(1.5U7 cm), equilibrated in 10 mM Na-HEPES, 0.2 M NaCl, pH 7.4.
Cleavage by factor Xa and isolation of phosphorylated hPAH(Ser-2-
Ser-110) was performed in the same way as for the non-phosphoryl-
ated form (see above). In order to study the rate of phosphorylation
for wt-hPAH and its N-terminal fragment, aliquots were taken out
from the phosphorylation mixture at di¡erent times and the reaction
stopped by addition of electrophoresis bu¡er containing SDS, fol-
lowed by incubation at 95‡C. Gels were analyzed by SDS-PAGE
and autoradiography [5].
2.5. Infrared spectroscopy
Samples of hPAH for IR spectroscopy were prepared by dissolving
the lyophilized protein in 20 mM Na-HEPES, 150 mM NaCl, pH or
pD (H2O- or D2O-based bu¡ers) 7.4, except for the samples of the N-
terminal fragment in which the pH (pD) was originally 8.0 and it was
adjusted to 7.4 after the protein was dissolved. Prior to the measure-
ments, samples were centrifuged (10 min at 15 000Ug) to remove any
protein aggregates. The protein concentration was 14^18 mg/ml, ex-
cept for the N-terminal fragment which was 4^5 mg/ml due to its
reduced solubility. Samples were assembled in a thermostated cell
between two CaF2 windows with a pathlength of 6 Wm (H2O) or 50
Wm (D2O). Samples in deuterated bu¡er were left 3 h at room temper-
ature to allow isotopic substitution of the protein exchangeable NH
protons. Spectra were recorded in Nicolet 520 (D2O samples) or Mag-
na 550 (H2O samples) spectrometers equipped with MCT detectors. A
total of 450 (D2O) and 1000 (H2O) scans were accumulated for each
spectrum, using a shuttle device. To study the thermal stability, sam-
ples were heated in steps of about 3‡C in the interval of 25^85‡C.
After each heating step, the sample was left to equilibrate for 5 min
and the corresponding spectrum recorded. Solvent subtraction, decon-
volution, determination of band position and curve ¢tting of the orig-
inal amide I band were performed as described [11].
2.6. Other methods
SDS-12% PAGE was performed at 12 mA (2.5 h), and the gels
stained by Coomassie brilliant blue. Protein concentration was esti-
mated [12] using as standard proteins puri¢ed fusion protein and
isolated wt-hPAH, having the absorption coe⁄cients A280 nm (1 mg
ml31 cm31) = 1.63 and 1.0, respectively [4]. Preparative and analytical
size exclusion chromatography was performed at 4‡C using a HiLoad
Superdex 200 HR column (1.6 cmU60 cm) as described [1,4]. The
catalytic activity of wt-hPAH and its truncated forms was measured
as described [4].
3. Results
3.1. Isolation of the multiple forms of hPAH and
phosphorylation of the N-terminal fragment
hPAH(Ser-2-Ser-110)
The tetrameric and dimeric forms of wt-hPAH, the tetra-
meric truncated form hPAH(Asp-112-Lys-452), and the di-
meric truncated mutant hPAH(Ser-2-Gln-428) were isolated
to homogeneity [1]. The fusion protein MBP-(pep)Xa-
hPAH(Ser-2-Ser-110) was expressed in E. coli. A⁄nity chro-
matography yielded 3^5 mg of homogeneous protein per litre
of culture (vs. 20^25 mg/l obtained for wt-hPAH) and the N-
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Fig. 1. Puri¢cation and phosphorylation of the N-terminal fragment
of human phenylalanine hydroxylase. A: Puri¢cation and e¡ect of
phosphorylation on the electrophoretic mobility on SDS-PAGE.
Lane 1, low molecular mass standards; lanes 2 and 3, non-phos-
phorylated and phosphorylated fusion protein MBP-(pep)Xa-
hPAH(Ser-2-Ser-110), respectively; lanes 4 and 5, non-phospho-
rylated and phosphorylated N-terminal fragment hPAH(Ser-2-Ser-
110), respectively; lane 6, extra low molecular mass standards: myo-
globin peptides residues 1^131 (14 kDa) and residues 56^153 (11
kDa). B: Rate of phosphorylation of wt-hPAH (b) or N-terminal
fragment, hPAH(Ser-2-Ser-110) (a). The fusion proteins were incu-
bated with the catalytic subunit of PKA at 30‡C in a phosphoryl-
ation assay mix, and aliquots were removed and tested for incorpo-
rated phosphate at the indicated times as described in Section 2.
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terminal fragment was isolated following cleavage of the fu-
sion protein by the restriction protease factor Xa (Fig. 1A).
The fragment was devoid of catalytic activity, and on size
exclusion chromatography it was recovered mainly in a mono-
meric form, although there were also high molecular mass
aggregates that could be removed by centrifugation (data
not shown). On phosphorylation by PKA its mobility on
SDS-PAGE decreased, as also observed for its parent fusion
protein (Fig. 1A). The apparent molecular mass increased
from 55.4 to 57.6 kDa for the fusion protein and from 12.8
to 14.9 kDa for the isolated fragment on phosphorylation. A
similar shift in the electrophoretic mobility following phos-
phorylation at Ser-16 is a characteristic feature of the human
enzyme and is not observed for the rat enzyme [4,5]. A com-
plete shift in electrophoretic mobility correlated with a stoi-
chiometry of 1 mol of phosphate/mol of protein subunit, and
the rate of phosphorylation by PKA can be followed by SDS-
PAGE. The N-terminal fragment incorporated 1 mol phos-
phate/mol subunit at comparable rates to wt-hPAH (Fig. 1B),
indicating a similar accessibility and folding around the phos-
phorylation site for both proteins.
3.2. Conformational properties of the di¡erent hPAH forms
The IR spectrum (recorded in D2O bu¡er) of tetrameric wt-
hPAH (Fig. 2A) revealed four band components in the amide
I region (1700^1600 cm31) after deconvolution. The dominant
band at 1654 cm31 re£ects a high content of K-helical struc-
ture. The band component at 1636 cm31 indicates the pres-
ence of L-structure, although, as it has been described for
human tyrosine hydroxylase (TH), it can also contain contri-
butions from non-structured conformations [13]. The fact that
the latter overlaps with the vibration of the helical component
in H2O (data not shown), made it possible to estimate its
relative content by a comparison of the spectra recorded in
both solvents. The increase of the band area of the 1636 cm31
band component, and its upward shift (1^2 cm31) upon deut-
eration further reinforces that this component contains con-
tributions from both types of secondary structures. The band
at 1627 cm31 has been assigned to protein segments in an
extended con¢guration, with their peptide residues not form-
ing intramolecular L-sheets, but rather hydrogen bonded to
other molecular structures [11,14]. Finally, the component
band at 1677 cm31 has been associated to L-turns [15,16].
The secondary structure of wt-PAH as obtained from the
combined values obtained in H2O and D2O media is shown
in Table 1. Similar values were estimated for the dimeric form
of wt-hPAH, which after isolation remains as 90^95% dimeric
[1] (data nor shown).
The IR spectrum of the truncated protein hPAH(Asp-112-
Lys-452), lacking the N-terminal domain, displayed the same
number of band components at similar positions as wt-hPAH
(Fig. 1B). However, the intensity of the band at 1636 cm31 is
signi¢cantly lower for the truncated protein, which can be
interpreted as a decrease in the content of L- and/or non-
regular structures upon removal of the N-terminal domain
of the protein. In support of this interpretation is the fact
that the relative intensity of the band components at 1655
cm31 and 1635 cm31 is almost identical in the spectra re-
corded in H2O and D2O. Taking this into account, the regu-
latory N-terminal domain is expected to be composed mainly
of unordered structures with few segments of periodic second-
ary structure, which indeed was observed in the IR spectrum
of this domain (Fig. 2C). The absorption maximum of the
amide I band appears at 1645 cm31, a frequency that has
been associated with unstructured protein conformations.
The fact that deconvolution is not able to resolve the band
components as clearly as in the other two forms of the en-
zyme, indicates that their bandwidths are larger, a character-
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Table 1
Estimation of the relative amount (%) of di¡erent secondary structures in wild-type and truncated forms of human phenylalanine hydroxylasea
hPAH (2^452) hPAH (112^452) hPAH (2^110) hPAH Pi(2^110) hPAH (2^428)
K-Helix 48 58 14 22 46
Extended structures (including L-sheet) 28 28 27
52b 52b
Unordered 12 2 14
L-Turns 12 12 34 26 13
aThe values are rounded o¡ to the nearest integer.
bThese values include extended and unordered conformations.
Fig. 2. Deconvolved infrared spectra of human phenylalanine hy-
droxylase (hPAH) and its truncated forms in deuterated bu¡er.
A: wt-hPAH; B: hPAH(Asp-112-Lys-452), C-terminal domain;
C: hPAH(Ser-2-Ser-110), N-terminal domain; and D: hPAH(Ser-2-
Glu-428), stable dimer. All spectra were recorded at 25‡C. Deconvo-
lution was preformed using a Lorentzian line shape of 18 cm31 and
a resolution enhancement factor of 2.
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istic property of £exible, £uctuating protein conformations
[17]. Minor components at 1655 and 1630 cm31, revealed
that this domain also contains some regular secondary struc-
ture elements. Although the N-terminal domain had a ten-
dency to aggregate at concentrations higher than 5 mg/ml,
no signi¢cant component bands at 1684 and 1619 cm31, cor-
responding to aggregated, denatured protein [18], could be
observed in the spectrum of this domain, indicating that under
the experimental conditions used (i.e. below 5 mg/ml), the
fragment did not self-associate. The structural e¡ects of phos-
phorylation of the N-terminal fragment at Ser-16 were also
studied by IR spectroscopy. The sequence surrounding the
phosphorylatable residue (Ser-16) has been found for many
substrates of PKA and it has been predicted to lie within a L-
turn [19]. The e¡ects of phosphorylation of Ser-16 on the
secondary structure are summarized in Table 1. As compared
with the non-phosphorylated sample, it shows a higher
(V8%) content of helical structure and a concomitant de-
crease in L-turn conformations.
The C-terminal 24 amino acids of hPAH consist of a hep-
tad repeat in an amphipatic K-helix [20] as in rat TH, where it
represents the tetramerization domain, involved in the forma-
tion of tetramers by domain swapping [6]. Removal of this C-
terminal fragment generates a catalytically active dimer
hPAH(Ser-2-Gln-428) [1]. The IR spectrum of this dimer
shows the same spectral features as that of wt-hPAH (both
dimeric and tetrameric forms), with regard to the number,
position and intensity of their band components (Fig. 2D).
Therefore, the secondary structure of the protein remains es-
sentially unaltered upon tetramerization (Table 1). Interpreta-
tion of the observed di¡erences between the molecular forms
of hPAH based on percentage changes are not straightfor-
ward, since they contain di¡erent numbers of amino acids.
To better visualize these di¡erences other parameters such
as band area ratios, which isolate two components and
make them comparable between two samples, must be used
(Table 2). The ratio K-helix/extended structures (1654/
1636+1625) increases after deleting the 111 amino acid frag-
ment at the N-terminal, as does the ratio K-helix/unordered
(7-fold increase). It should be noted that the low solubility of
the N-terminal fragment hampers data acquisition in H2O
medium. Therefore, the amount of unordered structure can-
not be accurately determined. Nevertheless, from the data
obtained it is clear that both band ratios mentioned above
decrease signi¢cantly for this protein fragment.
3.3. Thermal stability studies
The thermal stability of the full-length protein and its trun-
cated forms was also studied by IR spectroscopy. As observed
for many soluble proteins [11,18], thermal denaturation of
hPAH is accompanied by drastic changes in the amide I
band contour. The most characteristic one is the appearance
of two component bands at 1684 and 1619 cm31 in the spec-
trum of the thermally denatured protein, that have been as-
signed to the aggregation of denatured protein molecules
[18,21] (data not shown). From these spectral changes the
thermal stability of the enzyme forms was estimated by fol-
lowing the intensity ratio of the amide I band at 1619 cm31
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Table 2
Percentage ratios of di¡erent secondary structure elements of hPAH and its deletion mutants
hPAH (2^452) hPAH (112^452) hPAH (2^110) hPAH Pi(2^110) hPAH (2^428)
K/extended 1.7 2.1 n.d. n.d. 1.7
K/extended+unordered 1.2 1.9 0.3 0.4 1.1
K/unordered 4.0 29.0 n.d. n.d. 3.3
K/turns 4.0 4.8 0.4 0.8 3.5
n.d., not determined.
Fig. 3. Thermal stability of human phenylalanine hydroxylase and
selected truncated forms of the enzyme. A: Ratio of amide I band
intensity at 1618 cm31 to that at 1650 cm31, in the absence of L-
Phe, as a function of temperature for wt-hPAH (b) ; hPAH(Asp-
112-Lys-452), C-terminal domain (F) ; hPAH(Ser-2-Ser-110), N-ter-
minal domain (S) ; and hPAH(Ser-2-Glu-428), stable dimer (P). B:
Temperature dependence of I1618/I1650 for wt-hPAH (b, a) and its
C-terminal domain (F, E) in the absence (¢lled symbols) and pres-
ence (empty symbols) of 1 mM L-Phe.
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and 1650 cm31 (I1619/I1650) [13] (Fig. 3). The cooperative un-
folding of tetrameric wt-hPAH shows a midpoint denatura-
tion temperature (Tm) at 57‡C, that decreases to 49‡C upon
removing the N-terminal domain (Fig. 3A). On the other
hand, the thermal unfolding of the non-phosphorylated N-
terminal regulatory domain shows a gradual, non-cooperative
process which has also been observed for £exible protein con-
formations lacking stable tertiary structures [14,22] (Fig. 3A).
The higher value of the amide I bandwidth at half-height
obtained for this sample (51 cm31) as compared with those
of wt-hPAH and hPAH(Asp-112-Lys-452) (42 cm31), is in
agreement with this idea. In spite of the above mentioned
increase in K-helical structure observed upon phosphorylation
of the N-terminal domain, its thermal stability pro¢le is sim-
ilar to that of the non-phosphorylated sample (data not
shown). The deletion of the tetramerization domain had no
signi¢cant e¡ect on the Tm (Fig. 3A), indicating that this
domain does not play an important role in maintaining the
thermal stability of the enzyme.
Incubation of wt-hPAH and the C-terminal domain hPA-
H(Asp-112-Lys-452) with L-Phe results in an activation of
both enzyme forms [1], that is not accompanied by noticeable
changes of their secondary structure (results not shown).
However, the thermal stability of the truncated, but not that
of the wild-type enzyme increases. The midpoint denaturation
temperature of the former shifts from 49‡C to 56‡C, while
that of wt-hPAH remains the same upon incubation with L-
Phe (Fig. 3B).
4. Discussion
The three tetrahydrobiopterin-dependent aromatic amino
acid hydroxylases have a highly conserved amino acid se-
quence at the C-terminal catalytic domain, and a less con-
served sequence at the N-terminal regulatory domain which
account for some of the catalytic and regulatory properties of
the enzymes [23]. In the present study infrared spectroscopy
has been applied to wt-hPAH and three truncated forms of
the enzyme to elucidate the conformation of the catalytic and
regulatory domains of the protein. The ability of the isolated
domains to fold into native-like structures is demonstrated,
among others, by (i) the C-terminal region (Asp-112-Lys-
452) shows catalytic activity and forms tetramers [1], and
(ii) the N-terminal fragment (Ser-2-Ser-110) is phosphorylated
at the same stoichiometry and comparable rate as the wild-
type enzyme by PKA, which changes its mobility on SDS-
PAGE. The isolated domains of TH have also been shown
to fold independently in a functional conformation [24]. Our
results clearly demonstrate that the secondary structure ele-
ments of hPAH are segregated into two domains. While the
catalytic domain is highly K-helical, the conformation of the
N-terminal regulatory domain is more £exible and contains a
higher relative content of turns and non-regular structures.
The high content of K-helical structure of the C-terminal frag-
ment is in good agreement with the secondary structure pre-
dicted using the PHD algorithm [25], that has given reliable
data for the catalytic domain of TH [6]. The similar secondary
structure and thermal stability of hPAH (present study) and
TH [12] is in good agreement with the prediction that these
proteins share a common overall fold [23].
The activation of PAH by incubation with its substrate (L-
Phe) seems to induce changes in the tertiary and/or quater-
nary structure of the enzyme, probably resulting from homo-
tropic cooperative interactions between the catalytic sites in
the tetrameric enzyme [26]. This conclusion is further sup-
ported by an increase in volume of the tetrameric protein
[27], the displacement of Trp-120 from a relatively hydropho-
bic to a hydrophilic (solvent) environment [28] and by a shift
of the dimer:tetramer equilibrium towards the tetrameric
form [4] upon binding of L-Phe. As seen from the present
IR studies, these changes are not accompanied by measurable
changes in the secondary structure. Moreover, it has been
postulated that activation of PAH involves changes in the
interactions between the catalytic and the regulatory domains
which modify the accessibility of the active site for substrate
binding. Thus, removal of the regulatory domain seems to
expose the active site, relieving its inhibitory e¡ect on the
catalytic domain [1,29,30]. The existence of electrostatic inter-
actions between the two domains which are changed on phos-
phorylation of the enzyme has also been postulated [31]. How-
ever, direct experimental evidence for the existence of such
interactions is scarce. In this context, the lower thermal stabil-
ity of the C-terminal domain (hPAH(Asp-112-Lys-452)) as
compared to wt-hPAH, suggests that in the full-length protein
the interaction between the two domains exerts a stabilizing
e¡ect. Accordingly, the displacement of the N-terminal do-
main on activation by the substrate may result in a destabili-
zation of the enzyme which could be masked by the stabilizing
e¡ect of the substrate binding at the active site, as seen for
hPAH(Asp-112-Lys-452) on incubation with L-Phe. More-
over, as shown here, the increase in the helical content of
the N-terminal domain upon activation of the enzyme by
phosphorylation could be involved in the modi¢cation of
the interactions between domains which regulates access of
substrates to the active site. A similar increase in K-helical
content has been found upon phosphorylation of human
TH, reinforcing their structural homology [13].
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